Clearmind Medicine, Inc. (CMND)
5.98
-0.14
(-2.31%)
USD |
NASDAQ |
Oct 27, 16:00
5.98
0.00 (0.00%)
After-Hours: 20:00
Clearmind Medicine Cash from Operations (Quarterly) : -1.859M for July 31, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -1.859M |
| April 30, 2026 | -1.792M |
| January 31, 2026 | -2.085M |
| October 31, 2025 | -1.260M |
| July 31, 2025 | -1.154M |
| April 30, 2025 | -1.098M |
| January 31, 2025 | -1.265M |
| October 31, 2024 | -1.086M |
| July 31, 2024 | -1.108M |
| April 30, 2024 | -1.188M |
| January 31, 2024 | -1.462M |
| October 31, 2023 | -0.6548M |
| July 31, 2023 | -1.442M |
| April 30, 2023 | -1.059M |
| January 31, 2023 | -3.103M |
| October 31, 2022 | -0.0909M |
| July 31, 2022 | -0.2363M |
| April 30, 2022 | -2.097M |
| Date | Value |
|---|---|
| January 31, 2022 | -1.411M |
| October 31, 2021 | -1.382M |
| July 31, 2021 | -0.3562M |
| April 30, 2021 | -0.4444M |
| January 31, 2021 | -0.0721M |
| October 31, 2020 | -0.0623M |
| July 31, 2020 | -0.0602M |
| April 30, 2020 | -0.0783M |
| January 31, 2020 | 0.0008M |
| October 31, 2019 | -0.0095M |
| July 31, 2019 | -0.0144M |
| April 30, 2019 | -0.0034M |
| January 31, 2019 | -0.0203M |
| October 31, 2018 | -0.0426M |
| July 31, 2018 | -0.005M |
| April 30, 2018 | -0.0136M |
| January 31, 2018 | -0.0199M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -2.909M |
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.53M |
| Appili Therapeutics, Inc. | -0.0267M |
| Lexaria Bioscience Corp. | -1.635M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.7625M |
| Cash from Financing (Quarterly) | 3.136M |
| Free Cash Flow | -6.997M |
| Free Cash Flow Per Share (Quarterly) | -9.400 |
| Free Cash Flow to Equity (Quarterly) | -3.572M |
| Free Cash Flow to Firm (Quarterly) | -1.854M |
| Free Cash Flow Yield | -1.86K% |